| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/04/2008 | US20080213381 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component |
| 09/04/2008 | US20080213380 Process for the Preparation of Encapsulates Through Precipitation |
| 09/04/2008 | US20080213379 tumor-selective targeting system for drug delivery wherein internalization of the drug occurs only in tumor cells and not in normal cells; causes receptor-mediated endocytosis |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213377 Delivery of Nanoparticles and/or Agents to Cells |
| 09/04/2008 | US20080213376 Medicament that is Intended for Oral Administration, Comprising a Cyclooxygenase-2 Inhibitor, and Preparation Method Thereof |
| 09/04/2008 | US20080213375 Drying of Drug-Containing Particles |
| 09/04/2008 | US20080213374 Multi-kinase inhibitor, chemotherapeutics, pain relievers, anti-depressants, anti-inflammatories, ondansetron, nabilone, dronabinol, antibiotics, and antivirals; renal cancer; immune system; viral, bacterial infections; nausea; vomiting; pain; non-renal cancer; fatigue; skin irritation; bone marrow |
| 09/04/2008 | US20080213373 Particles for Treatment of Pulmonary Infection |
| 09/04/2008 | US20080213371 Nanoparticulate poorly soluble ketoprofen, naproxen in crystalline, semi-crystalline, amorphous form; sugar, a sugar alcohol, a starch, a natural gum, a natural polymer water-soluble, water-dispersible excipient upon contact with saliva |
| 09/04/2008 | US20080213370 Suspensions of tacrolimus (FK506) anticancer particles with protein or polymer stabilizing agent; shorter administration times; reducing toxicity and hypersensitivity side effects |
| 09/04/2008 | US20080213369 Synthetic platelets |
| 09/04/2008 | US20080213368 Method for Stabilizing Anti-Dementia Drug |
| 09/04/2008 | US20080213367 Water soluble concentric multi-wall carbon nano tubes |
| 09/04/2008 | US20080213366 Therapeutic Compositions |
| 09/04/2008 | US20080213365 Vapor-deposited amorphous solid; lower fictive temperature based on enthalpy than liquid-cooled amorphous solid formed by melting vapor-deposited amorphous solid and cooling at1 K/min; opharmaceutical industry, glasses fabricated from pi-conjugated systems for electronics, optoelectronics |
| 09/04/2008 | US20080213364 Dissolution profile delivers increased amounts; overcome gastrointestinal side effects associated with high doses; croscarmellose sodium; povidone; microcrystalline cellulose; colloidal silicon dioxide; magnesium stearate; talc; sealing coat surrounding core; enteric coat |
| 09/04/2008 | US20080213363 Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
| 09/04/2008 | US20080213362 Diuretic treatment of edema and congestive heart failure; thiazolidinedione anti-diabetic agent, pioglitazone and rosiglitazone; three layered tablet; not worsen blood sugar levels or glycemic status; dose of about 2 mg or less of torsemide |
| 09/04/2008 | US20080213361 Coat sodium ibuprofenate crystals with finely divided silica excipient; microcrystalline cellulose; crosslinked polyvinylpyrrolidone binder; mannitol filler; stearic acid disintegrant; poloxamer lubricant; simpler, more cost-efficient; roll compaction, agglomerate, granulate; conventional compression |
| 09/04/2008 | US20080213360 Dry granulation binders, products, and use thereof |
| 09/04/2008 | US20080213359 Repair damaged bone; hemihydrate calcium sulfate particles, mixed with aqueous solution to obtain paste; additional growth factor agents to promote formation of new bone; autogenous bone graft; plastic reconstruction; joint fusion; reattachment of avulsed bone fragment; orthodontics |
| 09/04/2008 | US20080213358 Method And Device For Ultrasound-Pressing A Tablet Or A Multiparticulate Medicament |
| 09/04/2008 | US20080213357 Oil extracted from Boraginaceae arvensis seeds; stearidonic acid and gamma-linolenic acid, fatty acids, carrier; nutritional, cosmetic, personal care, pet care, aquaculture and pharmaceutical or healthcare products |
| 09/04/2008 | US20080213356 Sub-lingual tablet, capsule, sachet administration Fluvastatin or Atorvastatin; Dimethicone as stabilizer to inhibit isomerization, elimination, oxidation, recrystallization; binder, diluent, disintegrant, lubricant, glidant; bioavailable; sufficient shelf-life; good pharmacotechnical properties |
| 09/04/2008 | US20080213355 Polymer shell is biodegradable polylactide, polyglycolide; therapeutic drug and gas dissolved in solvent; drug released from shell by ultrasound rupture of shell; form shell by drop-by-drop emulsification; inkjet printing, cross-flow emulsification; remove solvent from emulsion by agitation, extraction |
| 09/04/2008 | US20080213354 Nanoparticles for protein drug delivery |
| 09/04/2008 | US20080213353 Liposomes encapsulate active agent; vehicles for the delivery of drugs and active agents as well as in the field of gene transfer; delayed, sustained or prolonged release, gradual release, timed release, pH dependent release |
| 09/04/2008 | US20080213352 Phosphatidylcholine phospholipid molecules suspended in aqueous solution; uniformly organized into vesicles of lipid bilayers; fullerenes uniformly distributed; therapeutic, diagnostic, cosmetics |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213350 Polycationic polymer complexes; delivery across blood brain barrier; tissue targeted gene therapy |
| 09/04/2008 | US20080213349 Liposome Complexes Containing Pharmaceutical Agents and Methods |
| 09/04/2008 | US20080213348 Nucleic acid encoding protein effective as hepatocyte growth factor; reducing brain damage caused by cerebral ischemic reperfusion injuries |
| 09/04/2008 | US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/04/2008 | US20080213346 Dispersing phospholipid in aqueous solution containing such as human growth hormone and shearing; repeat phospholipid addition and shearing multiple times with stepwise increase in force; efficiency; storage stability |
| 09/04/2008 | US20080213345 Delivering Iron to an Animal |
| 09/04/2008 | US20080213343 Oral, Quickly Disintegrating Film, which Cannot be Spit Out, for an Antiemetic or Antimigraine Agent |
| 09/04/2008 | US20080213341 Gastrointestinal tract protection; incorporating as food and/or beverage supplements |
| 09/04/2008 | US20080213339 Pharmaceutical Composition Containing Indometacin and/or Acemetacin |
| 09/04/2008 | US20080213338 Implant stent with a retinoid for improved biocompatibility |
| 09/04/2008 | US20080213334 Polyelectrolyte media for bioactive agent delivery |
| 09/04/2008 | US20080213330 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons |
| 09/04/2008 | US20080213324 Amphiphilic or lipophilic polar functionalized fullerenes and their uses |
| 09/04/2008 | US20080213321 Dermabrasion devices and systems |
| 09/04/2008 | US20080213320 Nutraceutical; digestive enzymes, peptidase, protease, bromelain, papain, amylase, lactase, lipase, hemicellulase; probiotics, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium breve, Bifidobacterium longum; stevia |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213306 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213193 Foam skin cream, uses of the foam skin protection cream and a process for its preparation |
| 09/04/2008 | US20080213192 Pressurized, nonfoaming aqueous emulsions containing methylparaben-based preservative systems having a pH at or above where methylparaben hydrolyzes; preservatives; vapor pressure; polar/nonpolar solvents cosmetics; household products; human/ veterinary drugs; sunscreen agents; cosmetics; hair/skin |
| 09/04/2008 | US20080213183 Free or Liposomal Gemcitabine Alone or in Combination with Free or Liposomal Idarubicin |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213177 Nanoparticles Comprising Rna Ligands |
| 09/04/2008 | DE102007010656A1 Drug formulation and galenics for treatment or healing of infected root of tooth, has endodontic pin, which is customized in size to be suited with circular medication compartment |
| 09/04/2008 | CA2686840A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | CA2685231A1 Breakthrough pain management |
| 09/04/2008 | CA2679529A1 Novel dosage form |
| 09/04/2008 | CA2679504A1 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 09/04/2008 | CA2679448A1 Methods and compositions for normalizing meibomian gland secretions |
| 09/04/2008 | CA2679420A1 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 09/04/2008 | CA2679168A1 Medicated chewing gum |
| 09/04/2008 | CA2679139A1 Method for preparing silica compositions, silica compositions and uses thereof |
| 09/04/2008 | CA2678582A1 Improvements in and relating to medicinal compositions |
| 09/04/2008 | CA2677772A1 Patch for cutaneous application |
| 09/04/2008 | CA2675953A1 Therapeutic agent for spinal cord injuries |
| 09/04/2008 | CA2675827A1 Spray administration of compositions including active agents such as peptides to the gastrointestinal tract |
| 09/04/2008 | CA2656044A1 Collagen scaffolds, medical implants with same and methods of use |
| 09/03/2008 | EP1964576A1 Aqueous disinfectant gel preparation |
| 09/03/2008 | EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 09/03/2008 | EP1964564A1 Breakthrough Pain Management |
| 09/03/2008 | EP1964559A1 Compositions for the prevention and treatment of vascular dementia |
| 09/03/2008 | EP1964553A1 Sustained release pharmaceutical composition of tolterodine |
| 09/03/2008 | EP1964552A1 Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids |
| 09/03/2008 | EP1964549A1 Orally disintegrating tablet comprising fat-soluble substance |
| 09/03/2008 | EP1964548A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/03/2008 | EP1964547A1 Adhesive topical composition having a barrier action on aphthous ulcers of the oral mucosa |
| 09/03/2008 | EP1963558A1 Method for preparing a textile material and textile material thus prepared and produced |
| 09/03/2008 | EP1963256A1 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 09/03/2008 | EP1962906A2 Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| 09/03/2008 | EP1962904A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 09/03/2008 | EP1962886A2 Stable protein formulations |
| 09/03/2008 | EP1962873A2 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| 09/03/2008 | EP1962870A2 Novel hydrogels and uses thereof |
| 09/03/2008 | EP1962866A2 Hydrophobic elastomeric polymer chemistry device for inhibiting the growth of onychomycosis and urushiol-induced allergic contact dermatitis |
| 09/03/2008 | EP1962845A2 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 09/03/2008 | EP1962844A2 Lansoprazole orally disintegrating tablets |
| 09/03/2008 | EP1962836A2 Treatment of length dependent neuropathy |
| 09/03/2008 | EP1962831A2 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 09/03/2008 | EP1962821A1 Transdermal administration of active agents , in particular diclofenac |
| 09/03/2008 | EP1962817A2 Transdermal delivery of meptazinol |
| 09/03/2008 | EP1962816A2 Lotion-treated tissue and towel |
| 09/03/2008 | EP1962815A1 Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers |
| 09/03/2008 | EP1962814A2 Crystalline pyrimidine nucleoside derivatives suspensions in capsules |
| 09/03/2008 | EP1962813A2 Controlled release compositions containing zolpidem |
| 09/03/2008 | EP1962812A1 Multilayered chromonic structures |
| 09/03/2008 | EP1962811A2 Solid preparation containing an insulin sensitizer |
| 09/03/2008 | EP1962810A2 Pharmaceutical compositions of short-acting hypnotic agents in modified-release forms and the procedures to prepare the mentioned formulations |
| 09/03/2008 | EP1962809A2 Microparticulate systems for the oral administration of biologically active substances |
| 09/03/2008 | EP1962808A2 Hcv prodrug formulation |
| 09/03/2008 | EP1962807A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions |